 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is our internal ID - starting with VT.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
- For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.
 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
Bosutinib (SKI-606) in Adult Patients With Recurrent Glioblastoma |
 |
 |
 |
 |
 |
 |
Keywords: |
 |
|
 |
 |
 |
 |
Phase: |
 |
Phase 2 |
 |
 |
 |
 |
 |
 |
Treatment ID#s: |
 |
VT2021
NCT01331291
|
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
60: Requires occasional assistance but is able to care for most of own needs |
 |
 |
 |
 |
Conditions: |
 |
Newly Diagnosed: N
Recurrent: Y
Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
05/04/2011 |
 |
 |
 |
 |
Tumor Types: |
 |
Glioblastoma Multiforme |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
|
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Chemotherapy Less-Toxics. |
 |
 |
 |
 |
Contact: |
 |
Mass. General Hospital - Brain Tumor Center Tracy Batchelor, MD, MPH Executive Director Brain Tumor Center Suite 315, Cox Building Boston, MA 02114 Phone:617-724-8770 Fax: (617)724-8769 Click here to send an email Website: brain.mgh.harvard.edu |
 |
 |
|
|